Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022: Increased Prevalence of Chronic Disorders Driving 7.8% Annual Growth
/PRNewswire/ -- The "Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022, By Derived Cell Type, By Application, By End-User" report has been added...
United States Axol Bioscience Axol Biosciencee Bristol Myers Squibb Ipierian Laura Wood Fujifilm Holdings Corporation Cellular Dynamics
Source: prnewswire.com